Sapience Therapeutics
Phase 2We're changing the tide to achieve the unachievable in oncology. Learn how we're redefining druggability, our approach to peptide therapeutics, and more.
Founded
2009
Focus
RNA & Gene Therapy
About
We're changing the tide to achieve the unachievable in oncology. Learn how we're redefining druggability, our approach to peptide therapeutics, and more.
Funding History
3Total raised: $73M
Series B$45MOrbiMedJun 15, 2022
Series A$25MAisling CapitalJun 15, 2020
Seed$3MUndisclosedJun 15, 2017
Company Info
TypePrivate
Founded2009
LocationTarrytown, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile